chr4-1001802-T-A
Variant summary
Our verdict is Pathogenic. Variant got 14 ACMG points: 14P and 0B. PM2PP3_StrongPP5_Very_Strong
The NM_000203.5(IDUA):c.713T>A(p.Leu238Gln) variant causes a missense change. The variant allele was found at a frequency of 0.00000561 in 1,604,640 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★).
Frequency
Consequence
NM_000203.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 14 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000197 AC: 3AN: 152184Hom.: 0 Cov.: 34
GnomAD3 exomes AF: 0.0000218 AC: 5AN: 229094Hom.: 0 AF XY: 0.0000239 AC XY: 3AN XY: 125528
GnomAD4 exome AF: 0.00000413 AC: 6AN: 1452456Hom.: 0 Cov.: 34 AF XY: 0.00000554 AC XY: 4AN XY: 722324
GnomAD4 genome AF: 0.0000197 AC: 3AN: 152184Hom.: 0 Cov.: 34 AF XY: 0.0000269 AC XY: 2AN XY: 74340
ClinVar
Submissions by phenotype
Mucopolysaccharidosis type 1 Pathogenic:3
- -
This sequence change replaces leucine, which is neutral and non-polar, with glutamine, which is neutral and polar, at codon 238 of the IDUA protein (p.Leu238Gln). This variant is present in population databases (rs148789453, gnomAD 0.008%). This missense change has been observed in individual(s) with mucopolysaccharidosis type I (PMID: 15300847, 24368159; Invitae). ClinVar contains an entry for this variant (Variation ID: 265418). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt IDUA protein function with a positive predictive value of 95%. This variant disrupts the p.Leu238 amino acid residue in IDUA. Other variant(s) that disrupt this residue have been observed in individuals with IDUA-related conditions (PMID: 21480867, 24368159), which suggests that this may be a clinically significant amino acid residue. For these reasons, this variant has been classified as Pathogenic. -
The p.Leu238Gln variant in IDUA has been reported in at least 7 individuals with mucopolysaccharidosis (MPS), segregated with disease in 4 affected relatives from 2 families (PMID: 24368159), and has been Identified in 0.014% (2/13914) of African chromosomes and 0.003% (3/102956) of European (non-Finnish) chromosomes by the Genome Aggregation Database (gnomAD, http://gnomad.broadinstitute.org; dbSNP rs148789453). Although this variant has been seen in the general population, its frequency is low enough to be consistent with a recessive carrier frequency. In vitro functional studies provide some evidence that the p.Leu238Gln variant may impact protein function (PMID: 15300847). However, these types of assays may not accurately represent biological function. Computational prediction tools and conservation analyses suggest that this variant may impact the protein, though this information is not predictive enough to determine pathogenicity. The presence of this variant in combination with reported pathogenic variants in 5 individuals with MPS increases the likelihood that the p.Leu238Gln variant is pathogenic (VariationID: 11908, 222994; PMID: 24368159). The phenotype of individuals compound heterozygous for this variant is highly specific for MPS based on alpha-L-iduronidase activity being <1%, consistent with disease (PMID: 15300847). In summary, this variant meets criteria to be classified as pathogenic for MPS in an autosomal recessive manner based on the presence of the variant in combination with known pathogenic variants, functional studies, cosegregation, and the phenotype of individuals with the variant and MPS being highly specific for IDUA. ACMG/AMP Criteria applied: PM3_strong, PS3_moderate, PM2_supporting, PP3, PP4, PP1 (Richards 2015). -
not provided Pathogenic:2
- -
Published functional studies demonstrate that the L238Q variant causes reduced IDUA activity and protein levels when expressed in Chinese hamster ovary (CHO) cells (Yogalingam et al., 2004); In silico analysis, which includes protein predictors and evolutionary conservation, supports a deleterious effect; Not observed at significant frequency in large population cohorts (gnomAD); This variant is associated with the following publications: (PMID: 15300847, 24368159, 26260077, 31194252) -
IDUA-related disorder Pathogenic:1
The IDUA c.713T>A variant is predicted to result in the amino acid substitution p.Leu238Gln. This variant was reported along with second variant in several individuals with Mucopolysaccharidosis type 1 (Yogalingam et al. 2004. PubMed ID: 15300847; Ahmed et al. 2013. PubMed ID: 24368159). In vitro functional study demonstrated that this variant reduces IDUA activity to 5.88% of normal enzyme activity (Table 3, Yogalingam et al. 2004. PubMed ID: 15300847). Alternative variant at the same codon p.Leu238Arg has been observed in an individual with Mucopolysaccharidosis type 1 (Wang et al. 2011. PubMed ID: 21480867). This variant is reported in 0.014% of alleles in individuals of African descent in gnomAD. This variant is interpreted as pathogenic. -
Hurler syndrome Pathogenic:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at